Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anisotropic Black Phosphorus Synaptic Device for Neuromorphic Applications.

Advanced materials (Deerfield Beach, Fla.)·2016
Same author

An accurate clone-based haplotyping method by overlapping pool sequencing.

Nucleic acids research·2016
Same author

Upregulation of proangiogenic factors expression in the synovium of temporomandibular joint condylar hyperplasia.

Oral surgery, oral medicine, oral pathology and oral radiology·2016
Same author

Synthesis and Applications of π-Extended Naphthalene Diimides.

Chemical record (New York, N.Y.)·2016
Same author

Observation of the Singly Cabibbo-Suppressed Decay D^{+}→ωπ^{+} and Evidence for D^{0}→ωπ^{0}.

Physical review letters·2016
Same author

Circular RNAs: a new frontier in the study of human diseases.

Journal of medical genetics·2016

Related Experiment Video

Updated: Sep 15, 2025

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria
06:55

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria

Published on: August 4, 2022

1.9K

Three-stage sequential targeted nasal drops for correcting abnormal mitochondrial division in microglia.

Miaomiao Fei1, Qidong Liu1, Hui Zhang1

  • 1Department of Anesthesiology and Perioperative Medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, PR China.

Bioactive Materials
|July 18, 2025
PubMed
Summary

A novel nasal delivery system targets brain microglia to treat central nervous system (CNS) diseases by regulating mitochondrial division. This approach successfully delivered drugs and improved cognitive function in mouse models.

Keywords:
Abnormal mitochondrial divisionCNS diseasesHydrogel microspheresMicrogliaNasal drops

More Related Videos

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
08:15

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Published on: August 15, 2025

163
Mitochondrial Preparation from Microglia for Glycan Analysis
06:40

Mitochondrial Preparation from Microglia for Glycan Analysis

Published on: May 30, 2025

284

Related Experiment Videos

Last Updated: Sep 15, 2025

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria
06:55

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria

Published on: August 4, 2022

1.9K
Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
08:15

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs

Published on: August 15, 2025

163
Mitochondrial Preparation from Microglia for Glycan Analysis
06:40

Mitochondrial Preparation from Microglia for Glycan Analysis

Published on: May 30, 2025

284

Area of Science:

  • Neuroscience
  • Biotechnology
  • Pharmacology

Background:

  • Abnormal mitochondrial division in microglia is implicated in central nervous system (CNS) diseases.
  • Challenges in treating CNS diseases include drug delivery to the brain, microglial targeting, and mitochondrial regulation.

Purpose of the Study:

  • To develop a novel three-stage sequential targeted nasal drops delivery system for noninvasive treatment of CNS diseases.
  • To achieve precise drug delivery to brain lesions, target microglia, and regulate mitochondrial function.

Main Methods:

  • Selection of dehydroepiandrosterone (DHEA) as a key neurosteroid regulating mitochondrial fission.
  • Development of surface-positively charged hydrogel microspheres for nasal mucosa targeting.
  • Construction of targeted liposomes carrying cytotoxic T lymphocyte-associated protein-4, modified into microspheres for microglial CD80/86 receptor binding.
  • In situ release of DHEA to regulate dynamin-related protein 1, inhibiting abnormal mitochondrial division and microglial activation.

Main Results:

  • The three-stage sequential nasal drops efficiently traversed the nose-to-brain pathway in murine and porcine models.
  • The system successfully targeted activated microglia via CD80/86 receptors.
  • Treatment significantly ameliorated anesthesia/surgery-induced cognitive dysfunction in mice.
  • Mitochondrial morphology and function were stabilized, and microglial activation was inhibited.

Conclusions:

  • The developed three-stage sequential nasal drip system is a promising noninvasive strategy for treating CNS diseases.
  • This method offers precise drug delivery, effective microglial targeting, and mitochondrial regulation.
  • The system demonstrates potential for therapeutic intervention in neurological disorders.